MYGN

#4998
Myriad Genetics, Inc. - Common Stock
0.0 4 USD
-99.06%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.04
0.04
년간 변동
0.04
8.50
일일 변동
-99.06%
월간 변동
-99.15%
6달 변화
-99.47%
년간 변동율
-99.52%
이전 종가
4.2 2
Open
0.0 4
저가
0.0 4
High
0.0 4
양
448
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 3.75 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-1.56
주가매출액비율
0.69

Myriad Genetics, Inc. - Common Stock

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

뉴스